- Home
- KYMR vs BLKB Comparison
KYMR vs BLKB Comparison
Compare KYMR & BLKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- BLKB
- Stock Information
- Founded
- KYMR 2015
- BLKB 1981
- Country
- KYMR United States
- BLKB United States
- Employees
- KYMR N/A
- BLKB N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- BLKB Computer Software: Prepackaged Software
- Sector
- KYMR Health Care
- BLKB Technology
- Exchange
- KYMR Nasdaq
- BLKB Nasdaq
- Market Cap
- KYMR 3.1B
- BLKB 3.2B
- IPO Year
- KYMR 2020
- BLKB 2004
- Fundamental
- Price
- KYMR $47.28
- BLKB $69.63
- Analyst Decision
- KYMR Strong Buy
- BLKB Hold
- Analyst Count
- KYMR 15
- BLKB 3
- Target Price
- KYMR $58.53
- BLKB $78.67
- AVG Volume (30 Days)
- KYMR 599.5K
- BLKB 274.3K
- Earning Date
- KYMR 10-30-2025
- BLKB 10-29-2025
- Dividend Yield
- KYMR N/A
- BLKB N/A
- EPS Growth
- KYMR N/A
- BLKB N/A
- EPS
- KYMR N/A
- BLKB N/A
- Revenue
- KYMR $44,711,000.00
- BLKB $1,141,002,000.00
- Revenue This Year
- KYMR $58.45
- BLKB N/A
- Revenue Next Year
- KYMR N/A
- BLKB $4.18
- P/E Ratio
- KYMR N/A
- BLKB N/A
- Revenue Growth
- KYMR N/A
- BLKB 0.16
- 52 Week Low
- KYMR $19.45
- BLKB $58.05
- 52 Week High
- KYMR $53.27
- BLKB $88.95
- Technical
- Relative Strength Index (RSI)
- KYMR 64.57
- BLKB 64.61
- Support Level
- KYMR $42.71
- BLKB $66.50
- Resistance Level
- KYMR $44.43
- BLKB $70.34
- Average True Range (ATR)
- KYMR 1.98
- BLKB 1.50
- MACD
- KYMR 0.60
- BLKB 0.37
- Stochastic Oscillator
- KYMR 91.51
- BLKB 86.97
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.